NO175100C - Analogifremgangsmåte til fremstilling av terapeutisk aktive 4(3H)-pteridinoner - Google Patents

Analogifremgangsmåte til fremstilling av terapeutisk aktive 4(3H)-pteridinoner

Info

Publication number
NO175100C
NO175100C NO901430A NO901430A NO175100C NO 175100 C NO175100 C NO 175100C NO 901430 A NO901430 A NO 901430A NO 901430 A NO901430 A NO 901430A NO 175100 C NO175100 C NO 175100C
Authority
NO
Norway
Prior art keywords
pteridinones
preparation
therapeutically active
analogous process
analogous
Prior art date
Application number
NO901430A
Other languages
English (en)
Norwegian (no)
Other versions
NO901430D0 (no
NO901430L (no
NO175100B (no
Inventor
Gerard Ferrand
Herve Dumas
Jean-Claude Depin
Yvette Quentin
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of NO901430D0 publication Critical patent/NO901430D0/no
Publication of NO901430L publication Critical patent/NO901430L/no
Publication of NO175100B publication Critical patent/NO175100B/no
Publication of NO175100C publication Critical patent/NO175100C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO901430A 1989-03-30 1990-03-29 Analogifremgangsmåte til fremstilling av terapeutisk aktive 4(3H)-pteridinoner NO175100C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8904193A FR2645152B1 (fr) 1989-03-30 1989-03-30 3h-pteridinones-4, procedes de preparation et medicaments les contenant

Publications (4)

Publication Number Publication Date
NO901430D0 NO901430D0 (no) 1990-03-29
NO901430L NO901430L (no) 1990-10-01
NO175100B NO175100B (no) 1994-05-24
NO175100C true NO175100C (no) 1994-08-31

Family

ID=9380213

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901430A NO175100C (no) 1989-03-30 1990-03-29 Analogifremgangsmåte til fremstilling av terapeutisk aktive 4(3H)-pteridinoner

Country Status (30)

Country Link
US (1) US5167949A (cs)
EP (1) EP0399856B1 (cs)
JP (1) JPH0725761B2 (cs)
AR (1) AR248278A1 (cs)
AT (1) ATE126229T1 (cs)
AU (1) AU630178B2 (cs)
CA (1) CA2013324C (cs)
CZ (1) CZ284679B6 (cs)
DD (1) DD296927A5 (cs)
DE (1) DE69021444T2 (cs)
DK (1) DK0399856T3 (cs)
ES (1) ES2078324T3 (cs)
FR (1) FR2645152B1 (cs)
GE (1) GEP19971023B (cs)
GR (1) GR3017245T3 (cs)
HR (1) HRP920759B1 (cs)
HU (1) HU208826B (cs)
IE (1) IE68689B1 (cs)
IL (1) IL93914A (cs)
LV (1) LV5821B4 (cs)
MA (1) MA21786A1 (cs)
NO (1) NO175100C (cs)
NZ (1) NZ233130A (cs)
OA (1) OA09441A (cs)
PT (1) PT93600B (cs)
RU (1) RU1836344C (cs)
SI (1) SI9010633B (cs)
TN (1) TNSN90040A1 (cs)
YU (1) YU47346B (cs)
ZA (1) ZA902397B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270465A (en) * 1989-03-30 1993-12-14 Lipha, Lyonnaise Industrille Pharmaceutique 4(3H)-pteridinone compounds
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
US6806272B2 (en) 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
NZ531928A (en) * 2001-09-04 2005-10-28 Boehringer Ingelheim Pharma Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
FR2831789B1 (fr) * 2001-11-07 2004-01-23 Oreal Procede et dispositif pour l'evaluation de la secheresse cutanee notamment
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
EP1630163A1 (de) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
CA2680775A1 (en) * 2007-03-23 2008-10-02 F. Hoffmann-La Roche Ag Aza-pyridopyrimidinone derivatives
EP2185559A1 (en) 2007-08-03 2010-05-19 Boehringer Ingelheim International GmbH Crystalline form of a dihydropteridione derivative
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
US20150031699A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159628A (en) * 1962-05-28 1964-12-01 Smith Kline French Lab Pteridine-5-oxide derivatives
US3426019A (en) * 1962-06-29 1969-02-04 Smithkline Corp Derivatives of pteridine and a method for their preparation
SE307365B (cs) * 1966-05-28 1969-01-07 Yoshitomi Pharmaceutical
US3732224A (en) * 1969-10-20 1973-05-08 Sherwin Williams Co Method of controlling plant growth and 3-substituted lumazines used in such method
US3819631A (en) * 1970-12-15 1974-06-25 May & Baker Ltd Azapurinones
US3859287A (en) * 1971-05-05 1975-01-07 Walter Wesley Parish Thiopteridines and process for producing same
DE2232098A1 (de) * 1972-06-30 1974-01-17 Boehringer Mannheim Gmbh 2-alkyl-4(3h)-pteridinone und verfahren zu ihrer herstellung
US4183934A (en) * 1978-10-16 1980-01-15 Abbott Laboratories 4-Hydroxy-7-(substituted)phenylpteridines
US4361700A (en) * 1980-05-20 1982-11-30 James S. Waldron Pyridopyrimidinone derivatives

Also Published As

Publication number Publication date
ATE126229T1 (de) 1995-08-15
EP0399856A1 (fr) 1990-11-28
GEP19971023B (en) 1997-06-13
PT93600A (pt) 1990-11-20
DE69021444D1 (de) 1995-09-14
ES2078324T3 (es) 1995-12-16
PT93600B (pt) 1996-03-29
US5167949A (en) 1992-12-01
CA2013324A1 (fr) 1990-09-30
CZ152090A3 (cs) 1998-11-11
SI9010633A (en) 1997-02-28
RU1836344C (ru) 1993-08-23
IE901157L (en) 1990-09-30
NO901430D0 (no) 1990-03-29
LV5821B4 (lv) 1997-10-20
HRP920759B1 (en) 1998-08-31
IE68689B1 (en) 1996-07-10
HUT53646A (en) 1990-11-28
CA2013324C (fr) 2001-08-21
MA21786A1 (fr) 1990-10-01
AU5221890A (en) 1990-10-04
ZA902397B (en) 1991-01-30
FR2645152A1 (fr) 1990-10-05
SI9010633B (sl) 1999-06-30
HU208826B (en) 1994-01-28
HU901898D0 (en) 1990-08-28
NZ233130A (en) 1992-01-29
JPH02304089A (ja) 1990-12-17
FR2645152B1 (fr) 1991-05-31
NO901430L (no) 1990-10-01
AU630178B2 (en) 1992-10-22
GR3017245T3 (en) 1995-11-30
JPH0725761B2 (ja) 1995-03-22
EP0399856B1 (fr) 1995-08-09
IL93914A (en) 1994-02-27
OA09441A (fr) 1992-10-15
LV5821A4 (lv) 1997-04-20
DE69021444T2 (de) 1996-03-14
IL93914A0 (en) 1990-12-23
NO175100B (no) 1994-05-24
DK0399856T3 (da) 1995-09-18
YU63390A (en) 1991-10-31
AR248278A1 (es) 1995-07-12
YU47346B (sh) 1995-01-31
DD296927A5 (de) 1991-12-19
TNSN90040A1 (fr) 1991-03-05
CZ284679B6 (cs) 1999-02-17
HRP920759A2 (en) 1995-06-30

Similar Documents

Publication Publication Date Title
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO175100C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 4(3H)-pteridinoner
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI883739A7 (fi) Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
FI895393A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten alkyylisubstituoitujen 2-alkyyliamiinibentsopyran-6-olien valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI882002L (fi) Menetelmä terapeuttisesti aktiivisten fenyylipiperidiinijohdannaisten valmistamiseksi
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
FI100799B (fi) Menetelmä terapeuttisesti aktiivisten tetraliinijohdannaisten valmista miseksi
NO177712C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk virksomme alkylfosfonoseriner
FI893682L (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees